Table 5.
INN monoclonal antibody nomenclature scheme adopted at the 73rd INN Consultation held in Geneva during October 2021
| Prefix | Infix for target class | Suffix | |
|---|---|---|---|
| Random | -ami- | Serum amyloid protein (SAP)/amyloidosis |
-tug -bart -mig -ment |
| -ba- | Bacterial | ||
| -ci- | Cardiovascular | ||
| -de- | Metabolic or endocrine pathways | ||
| -eni- | Enzyme inhibition | ||
| -fung- | Fungal | ||
| -gro- | Growth factor and growth factor receptor | ||
| -ki- | Cytokine and cytokine receptor | ||
| -ler- | Allergen | ||
| -sto- | Immunostimulatory | ||
| -pru- | Immunosuppressive | ||
| -ne- | Neural | ||
| -os- | Bone | ||
| -ta- | Tumor | ||
| -toxa- | Toxin | ||
| -vet- | Veterinary use | ||
| -vi- | Viral | ||